Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 10, 2001, Pages 1627-1632

  Hernandez, L V ^a,b   Gilson, I ^a   Jacobson, J ^a   Affi, A ^a   Puetz, T R ^a   Dindzans, V J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b AURORA SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER TOXICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, TOXIC; HIV INFECTIONS; HUMANS; LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS;

EID: 0034794431     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01086.x     Document Type: Article

References (12)

1. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Reports of two patients and review of the literature
4. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
5. Drug-induced liver disease
6. Elevated liver enzymes in patients on protease inhibitors with and without markers for hepatitis: Results from the CHORUS observational database
7. Liver disease caused by hepatitis viruses as an emerging cause of hospital admission and death in HIV+IDUs
8. Acute hepatitis in HIV-infected patients during ritonavir treatment
9. Hepatotoxicity after introduction of highly active antiretroviral therapy
10. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
11. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection
12. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy